1d
Pharmaceutical Technology on MSNEC approves Otsuka and Lundbeck’s Rxulti for schizophreniaThe decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.
AI and 3D printing are being used to help in the treatment of schizophrenia in patients by helping doctors create specialized ...
For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...
Anyone who has seen Aish Dhanjah or knows his whereabouts is asked to contact the Detroit Police Department at 313-596-5240.
A research team led by Dr. Raymond Chan from the Institute of Psychology of the Chinese Academy of Sciences, together with ...
8d
MyNewsLA on MSNRiverside Police Seek Help Locating 32-Year-Old Woman With SchizophreniaAuthorities sought the public’s assistance Thursday in locating an at-risk 32-year-old woman diagnosed with schizophrenia and ...
Does mental illness reflect evolutionary traits gone awry? Emphasizing strengths over deficits helps people thrive.
The following is a summary of “Altered functional connectivity and hyperactivity of the caudal hippocampus in schizophrenia ...
A new approach that reframes mental health struggles not as defects but as understandable responses to stress and trauma ...
Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results